This study was undertaken to determine the effect of cyclophosphamide, methotrexate, hydrocortisone, and cyclosporin A on a model of granulomatous infiltration in the terminal ileum and draining lymph nodes of the guinea pig. Treatment 
I C Mitchell, J L Turk

Abstract
This study was undertaken to determine the effect of cyclophosphamide, methotrexate, hydrocortisone, and cyclosporin A on a model of granulomatous infiltration in the terminal ileum and draining lymph nodes of the guinea pig. Treatment groups of six animals were used and compared to untreated groups of 12. Epithelioid celi granulomas and primary macrophage granulomas were induced by the inoculation of BCG (Pasteur) and irradiated Mycobacterium leprae respectively into the terminal ileum of the guinea pig. The response to purified protein derivative of tuberculin was reduced in both groups of animals receiving any of these agents. Cyclophosphamide and methotrexate treated animals inoculated with BCG or M leprae showed a significant reduction of granulomatous infiltration at the inoculation site (p<0.05 and p<0-001 respectively). BCG inoculated animals treated with either hydrocortisone or cyclosporin A showed no reduction in granulomatous infiltration at either the inoculation site or the draining lymph nodes. By contrast M leprae inoculated animals receiving either of these agents showed a significant reduction of granulomatous infiltration at both the inoculation site (p<0.001) and in the primary draining lymph node (p<0001). Ziehl Neelsen staining showed an increased proportion of animals with detectable acid fast bacilli (AFB) at the inoculation site in the groups receiving hydrocortisone (50%) and methotrexate (67%) compared to untreated controls (8%). No AFB were observed in any of the animals inoculated with M leprae. In All animals apart from those in the hydrocortisone group underwent laparotomy on day 0 and started drug treatment on day 2. Animals receiving hydrocortisone were treated from day 0 with this drug before laparotomy and inoculation with mycobacteria on day 14 . All drugs were continued to the time of harvesting.
The doses of cyclophosphamide and methotrexate were based on those known to produce a loss of the delayed hypersensitivity reaction to picryl chloride and 2 phenyl-4-ethoxymethylene-5-oxazolone (oxazolone) in guinea pigs previously sensitised to them.3
The doses of hydrocortisone and cyclosporin Specimens were processed in a standard manner, embedded in wax, and representative 5 itm sections cut. In previous studies using this technique' no significant increase in the area of granulomatous infiltration recorded was achieved by examining multiple sections. However, in this study where the area of granulomatous infiltration was found to be greatly reduced, further sections were cut through the block to ensure that the relevant area had not been missed. Sequential sections were stained with haematoxylin and eosin and Ziehl Neelsen stains. The coded sections were read by the same observer (ICM) and demarcated as negative or positive depending on the presence of granulomas on H&E staining. If granulomatous infiltration was noted then its extent was measured using a projection microscope and planimeter.
In the case of lymph node sections, the areas of granulomatous infiltration and the total area of section were traced on to a white sheet using the projected image (x 36 magnification). The total area of section and the infiltrated area were measured using a fixed arm planimeter ( Acid fast bacilli were present with Ziehl Neelsen staining of sections of the large bowel granulomatous infiltrate after BCG inoculation, but only rarely in sections from the terminal ileal lesions. There was a corresponding reduction in sensitivity to skin testing with PPD in animals inoculated in the small bowel. This is in contrast to the results of previous work'2 which showed a greater skin test response with the same dose of PPD to live BCG and irradiated M leprae at similar doses and time integers when inoculated in the guinea pig ear.
The model was used to observe the effect of four immune modulating agents on granuloma formation in the gut. Cyclophosphamide and methotrexate reduced the areas of infiltration of both types of granuloma in the gut. Hydrocortisone and cyclosporin A reduced the area of infiltration of the phagocytic macrophage granuloma, but had no effect on the area of epithelioid granuloma infiltration. The response to PPD was reduced in all the treatment groups investigated.
Studies of the effect of cyclophosphamide and methotrexate on contact sensitivity in the guinea pig2'3 showed that if cyclophosphamide was started within two days of sensitisation then this was inhibited. There was a drop in the proportion of large pyroninophilic cells or T immunoblasts in the local lymph node at a time when the T lymphocytes are known to go into their maximum proliferative phase. Similar experiments using methotrexate again showed blockage of contact sensitivity but the action appeared to occur not directly on the large pyroninophilic cells but on the T cells that developed from them. In our experiments an increased number of animals in the group treated with methotrexate after inoculation with BCG showed acid fast bacilli, but this was not observed in the M leprae inoculated group. This may represent a drop in host resistance which could be related to decreased T lymphocyte function. Our findings are thus largely in keeping with those from earlier studies on contact sensitivity. It is perhaps surprising that cyclophosphamide had no effect on lymph node infiltration in the BCG granuloma. It is possible that this represents a difference in sensitivity or in the control process of the T lymphocyte subsets involved in the response to BCG. Previous studies using monoclonal antibodies on a model of similar granulomas induced in the posterior auricular lymph node of the guinea pig by the inoculation of these mycobacteria into the ear'3 showed the presence on the epithelioid cells of macrophage specific antigen but little evidence of major histocompatibility complex class II antigen. In contrast, the macrophages of the M leprae-induced granuloma expressed both macrophage specific and class II antigen. It 28 A marked reduction in macrophage activating factor has been noted in mice treated with higher doses of cyclosporin A (70 mg/kg/day).29 It is possible that this effect on lymphokine production is responsible for the failure of formation of a macrophage granuloma in response to M leprae in our model.
It is of interest that, clinically, Crohn's disease shows a considerable variation in its response to treatment with a variety of immunosuppressive agents. The lack of response to hydrocortisone and cyclosporin A seen in the live BCG induced bowel granulomas, which has the closest histological resemblance to Crohn's disease in our models, may be analogous to this.
In conclusion, it may be that the variation in response achieved clinically in patients with Crohn's disease using either glucocorticoids or cyclosporin A represents the overall balance of effect on a series of T lymphocyte subsets with differing potentials and susceptibilities. The trial of other therapeutic agents used in the treatment of clinical Crohn's disease, together with further work using monoclonal antibodies against differing T cell subsets might be of value in elucidating these observations. 
